Propanc Biopharma, Inc. (PPCB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 16.47M |
| Enterprise Value | 18.18M |
| P/E Ratio | -0.12 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.22 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.18 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.28 |
| Return On Equity | -1.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -58.34M |
| Net Income | -58.92M |
| Diluted EPS | -371.25 |
| Total Cash | 443,702 |
| Total Cash/Share | 0.49 |
| Total Debt | 1.57M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.37 |
| Book Value Per Share | 10.96 |
| 52-Week Change | -98.79 |
| 52-Week High | 270.25 |
| 52-Week Low | 1.3 |
| Moving Average 50 Days | 2.28 |
| Moving Average 200 Days | 18.56 |
| Average Volume | 129,695 |
| Shares Outstanding | 874,371 |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | May 18, 2026 |